De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination.
Langer
R M
RM
Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas 77030, USA.
Van Buren
C T
CT
Katz
S M
SM
Kahan
B D
BD
D000208:Acute Disease; D019540:Area Under Curve; D016572:Cyclosporine / Q000009:adverse effects* / Q000493:pharmacokinetics; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007239:Infections / Q000453:epidemiology; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011183:Postoperative Complications / Q000139:chemically induced* / Q000145:classification; D012189:Retrospective Studies; D020123:Sirolimus / Q000009:adverse effects*; D013997:Time Factors
D016572:Cyclosporine; D020123:Sirolimus